TD Asset Management
IRWD icon

TD Asset Management’s Ironwood Pharmaceuticals IRWD Stock Holding History

TD Asset Management’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-56,138
Closed -$636K – 1344
2019
Q1 		$636K Sell
56,138
-25,910
-32% -$289K ﹤0.01% 1139
2018
Q4 		$712K Sell
82,048
-162,920
-67% -$1.87M ﹤0.01% 1141
2018
Q3 		$3.79M Sell
244,968
-28,080
-10% -$444K 0.01% 813
2018
Q2 		$4.37M Sell
273,048
-15,760
-5% -$233K 0.01% 751
2018
Q1 		$3.73M Sell
288,808
-107,124
-27% -$1.33M 0.01% 740
2017
Q4 		$4.97M Buy
395,932
+22
+0% +$287 0.01% 667
2017
Q3 		$5.23M Buy
395,910
+7,000
+2% +$96.3K 0.01% 652
2017
Q2 		$6.15M Sell
388,910
-726
-0.2% -$10.5K 0.01% 634
2017
Q1 		$5.57M Buy
389,636
+24,239
+7% +$331K 0.01% 657
2016
Q4 		$4.68M Buy
365,397
+107,015
+41% +$1.35M 0.01% 698
2016
Q3 		$3.44M Buy
258,382
+26,865
+12% +$314K 0.01% 777
2016
Q2 		$2.54M Hold
231,517
– – ﹤0.01% 818
2016
Q1 		$2.12M Buy
231,517
+54,208
+31% +$447K ﹤0.01% 835
2015
Q4 		$1.72M Sell
177,309
-4,418
-2% -$42.7K ﹤0.01% 863
2015
Q3 		$1.59M Buy
181,727
+4,657
+3% +$43.5K ﹤0.01% 847
2015
Q2 		$1.79M Buy
177,070
+98,982
+127% +$1.15M ﹤0.01% 870
2015
Q1 		$1.05M Buy
78,088
+55,044
+239% +$722K ﹤0.01% 928
2014
Q4 		$296K Hold
23,044
– – ﹤0.01% 1234
2014
Q3 		$250K Hold
23,044
– – ﹤0.01% 1203
2014
Q2 		$296K Sell
23,044
-4,179
-15% -$45.4K ﹤0.01% 1148
2014
Q1 		$281K Buy
27,223
+5,015
+23% +$56.4K ﹤0.01% 1167
2013
Q4 		$216K Sell
22,208
-4,776
-18% -$42.9K ﹤0.01% 1215
2013
Q3 		$268K Buy
26,984
+3,343
+14% +$32.8K ﹤0.01% 1141
2013
Q2 		$197K Buy
+23,641
New +$287K ﹤0.01% 1137

Other funds holding IRWD

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
MP
MFN Partners Boston, Massachusetts $4.77B AUM 72.29% 1-Year Est. Return

TD Asset Management's IRWD Position: Q2 2019 in Review

TD Asset Management sold out of Ironwood Pharmaceuticals (IRWD) in Q2 2019, closing a stake of 56,138 shares — an estimated $636K sold.

TD Asset Management first reported a position in IRWD in Q2 2013 and held it in 24 quarters. The position peaked at $6.15M in Q2 2017. 152 funds tracked by Wall St. Rank hold IRWD as of Q2 2019.

  • TD Asset Management reported no remaining Ironwood Pharmaceuticals position as of Q2 2019 after selling out during the quarter.
  • TD Asset Management sold 56,138 Ironwood Pharmaceuticals shares in Q2 2019, an estimated $636K.
  • TD Asset Management first reported a position in Ironwood Pharmaceuticals in Q2 2013 and held it in 24 quarters.
  • TD Asset Management's Ironwood Pharmaceuticals position peaked at $6.15M in Q2 2017.
  • 152 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q2 2019.

Based on TD Asset Management's 13F filing for Q2 2019, filed 1 Aug 2019.